SSelectStock

ASTERDMAster DM Healthcare Limited

Healthcare · Medical Care Facilities · NSE · as of 2026-09-11 (delayed ~30 min in market hours)

Aster DM Quality Care Limited operates as an integrated healthcare provider in India. The company operates through four healthcare brands including Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH. It offers comprehensive healthcare services including primary, secondary, tertiary and quaternary care across key areas including oncology, cardiac sciences, neurosciences, gastro sciences, orthopedics, nephrology, organ transplantation, mother and childcare, and critical care. In addition, the company operates retail pharmacies and optical outlets. Aster DM Quality Care Limited was formerly known as Aster DM Healthcare Limited and changed its name to Aster DM Quality Care Limited in July 2026. The company was founded in 1987 and is based in Bengaluru, India.

763.05
0.45%
52Average

Mkt Cap
₹66,416 Cr
P/E
103.5
P/B
8.6
Div Yield
0.51%
52W High
₹891.30
52W Low
₹516.84

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)66,416.00
P/E103.53
P/B8.62
PEG1.38
ROE %10.07
ROCE %9.40
Debt / Equity0.46
EPS7.37
Revenue Growth %18.20
Profit Growth %71.50
Dividend Yield %0.51
Promoter Holding %59.74
FII Holding %20.16
DII Holding %
Beta-0.04

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on ASTERDM — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.

HOLDConviction 61%

The picture

  • Revenue growth: 18.2% YoY
  • Profit growth: 71.5% YoY
  • Debt/Equity: 0.46
  • MACD: bullish
  • Price vs SMA200: above
  • Golden cross setup: SMA50 above SMA200

Bull case

  • Revenue growth: 18.2% YoY
  • Profit growth: 71.5% YoY
  • Debt/Equity: 0.46
  • MACD: bullish

Bear case

  • ROE: 10.1%
  • ROCE: 9.4%
  • RSI: 41
  • Price vs EMA21: below

Key risks

  • ROE: 10.1%
  • ROCE: 9.4%

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹763.05
Stop Loss
₹736.56
risk 3.5%
Target 1 (1.5R)
₹802.78
+5.2%
Target 2 (3R)
₹842.52
+10.4%
Support (20d)
₹744.00
Resistance (52w)
₹891.30
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹26.49/share
ATR (volatility)
₹21.01
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹21.01). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental61
Technical42
Momentum45
Risk (safety)64

Peers — Healthcare

GKSL 1.23%
79
NEPHROPLUS 2.42%
74
KOVAI 1.41%
73
SAILIFE 0.38%
73
METROPOLIS 1.70%
73
VIJAYA 0.21%
72